The purpose of this study was to determine whether the presence of diabetes mellitus (DM) influences the incidence and severity of peripheral sensory neuropathy (PSN) in patients using taxane therapy. A retrospective single-center analysis was conducted: Patients with PSN at baseline were excluded.

READ FULL ARTICLE Curated publisher From Springer